Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 3, 2016
Patent Application Number
14450000
Date Filed
August 1, 2014
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present disclosure relates to compositions and methods for treating retinal damage and/or retinal degradation. More specifically, this disclosure relates to methods for treating degradation of the retinal pigment epithelium by administering compositions comprising a nucleoside and/or a nucleoside or nucleotide reverse transcriptase inhibitor.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.